Chad Byers
Co-founder & General Partner at Susa Ventures
Chad Byers is a prominent figure in the venture capital industry, based in the San Francisco Bay Area. He is the Co-founder and General Partner at Susa Ventures, a seed-stage venture capital firm he established in January 2013.1
At Susa Ventures, Byers focuses on investments in healthcare, fintech, and supply chain sectors.2 He has led several notable investments, including seed rounds for companies that have since achieved unicorn status, such as Robinhood, Flexport, Andela, Newfront Insurance, Stord, and Mux.12
Byers has received recognition for his work in venture capital:
- He was named to the Forbes 30 Under 30 for Venture Capital in 2015.1
- He appeared on the Forbes Midas Seed List, ranking #14 in May 2022.1
Prior to founding Susa Ventures, Byers worked at various startups in product and marketing roles.2 His background includes:
- A bachelor's degree in Environmental Science from the University of Colorado.2
- Early exposure to entrepreneurship and venture capital, having been raised in Silicon Valley.2
As an investor at Flexport since 2014, Byers has been involved with the company's growth from its early stages.1 Flexport has since reached a valuation of $8 billion.1
Byers is active on social media, maintaining a presence on Twitter (@chadbyers) where he describes himself as investing $1m+ into pre-seed and seed rounds, with a focus on software companies.3
Highlights
Thanks for having me, had a blast! The energy of Silicon Valley builders is the best — easy to be optimistic about the future around a group like this.
When someone is having a stroke, they lose 2 million brain cells a minute.
Viz's algorithms, which analyze a patient’s various tests and scans to help diagnose stroke and other emergencies, can already shave off 66 minutes of the time it takes for stroke patients to receive specialized care.
As a result, they are now in 1,600 hospitals in the US.
Fun read on one of the most meaningful seed investments of my career.
Congrats to the co-founder and CEO, Chris Mansi, on this well deserved recognition. A true pioneer on bringing AI into modern healthcare.